Case studies

Accelerating clinical trial recruitment in schizophrenia: a clinical research study

Read More

ePatient Insights: clinical trial recruitment in the age of the epatient

Read More

Using online tools in rare disease: the DevelopAKUre clinical research study

Read More

Online recruitment support for Type 1 diabetes study

Read More

Raising awareness of the early symptoms of Alzheimer’s: a clinical research study

Read More

Educating doctors with personal stories in mental illness: Rethink

Read More

Building online health communities: Hepatitis C News

Read More

Raising awareness of pre-eclampsia in pregnant women

Read More

Meet the scientists: personal perspectives from the leaders of Roche pRED

Read More

Testimonials

“You are great professionals and you really made the filming easier for us without compromising quality.”

— Dr María José de Castro López; Department of Paediatrics, University Hospital of Santiago de Compostela, Spain

“The Tudor Reilly team are the consummate professionals; a pleasure and a delight to work with.”

— Strategic Business Communications Partner, Roche

“Many thanks for all your hard work. You guys are the best.”

— Head of the Drug Discovery and Development Unit, Italian Institute of Technology

“Tudor Reilly understands both sides of the business: from the tiny biotech just starting in discovery to the giant pharmaceutical marketing global brands.”

— Managing Director, Versant Ventures

“I want to thank the Tudor Reilly team for all you’ve done for us on the study start-up team. You’ve been positive, helpful, professional, collaborative and knowledgeable – just great vendors.”

— Project Manager, Top 10 international CRO

“None of us could have asked for more. Great pleasure working with you.”

— Director, National Institutes of Health

“Working with Tudor Reilly, we could be assured of working with a team with great ideas, creativity and heritage.”

— Senior Communications Specialist, Sanofi UK

“The Tudor Reilly team has been amazing, making a significant contribution to our patient recruitment strategy for our international clinical trials.”

— Rare disease patient group, AKU Society